GIP/GLP-1a
UAEU_CMHS_IM_startup_AA01
Phase 2 small_molecule active
Quick answer
GIP/GLP-1a for Non-Alcoholic Fatty Liver Disease is a Phase 2 program (small_molecule) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).
Program details
- Company
- UNITED THERAPEUTICS Corp
- Indication
- Non-Alcoholic Fatty Liver Disease
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active